Nisa Investment Advisors LLC Acquires 12,126 Shares of HCA Healthcare, Inc. $HCA

Nisa Investment Advisors LLC raised its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 20.7% during the fourth quarter, HoldingsChannel reports. The firm owned 70,580 shares of the company’s stock after buying an additional 12,126 shares during the quarter. Nisa Investment Advisors LLC’s holdings in HCA Healthcare were worth $32,951,000 at the end of the most recent quarter.

Other large investors have also recently modified their holdings of the company. Holos Integrated Wealth LLC purchased a new stake in HCA Healthcare during the 4th quarter valued at $29,000. Palisade Asset Management LLC purchased a new stake in shares of HCA Healthcare in the third quarter valued at $26,000. Aventura Private Wealth LLC purchased a new position in shares of HCA Healthcare during the 4th quarter worth about $34,000. Harbor Capital Advisors Inc. grew its holdings in HCA Healthcare by 82.9% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 75 shares of the company’s stock valued at $32,000 after purchasing an additional 34 shares during the last quarter. Finally, JPL Wealth Management LLC purchased a new position in HCA Healthcare in the 3rd quarter worth about $33,000. Institutional investors own 62.73% of the company’s stock.

Analyst Upgrades and Downgrades

HCA has been the topic of a number of research analyst reports. JPMorgan Chase & Co. upped their target price on shares of HCA Healthcare from $420.00 to $535.00 and gave the stock a “neutral” rating in a research note on Friday, February 20th. Morgan Stanley cut HCA Healthcare from an “equal weight” rating to an “underweight” rating and set a $425.00 price objective on the stock. in a research note on Monday, December 15th. Wells Fargo & Company increased their price objective on shares of HCA Healthcare from $452.00 to $481.00 and gave the company an “equal weight” rating in a research note on Friday, January 30th. Deutsche Bank Aktiengesellschaft raised their price objective on HCA Healthcare from $500.00 to $558.00 and gave the company a “buy” rating in a research report on Wednesday, January 28th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of HCA Healthcare in a research report on Wednesday, March 4th. Sixteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $537.73.

Key Headlines Impacting HCA Healthcare

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: Q4 earnings and guidance — HCA reported a sizeable EPS beat (reported $8.01 vs. $7.37 consensus), revenue rose ~6.7% year-over-year (slightly below sales estimates) and management set FY2026 EPS guidance of $29.10–$31.50, which supports a re-rating and underpins near-term investor optimism. Reflecting on hospital chains stocks Q4 earnings: HCA Healthcare (NYSE:HCA)
• Positive Sentiment: State approval for new Chesterfield hospital projects — Virginia’s commissioner approved HCA’s Chesterfield hospital developments after initial staff hesitation, clearing the way for expansion that can add bed capacity and local market share. VDH staff initially wanted to deny new Chesterfield HCA hospital. Why did the commissioner approve it?
• Positive Sentiment: Local leadership hires — HCA named a new CEO at TriStar StoneCrest Medical Center and announced C-suite appointments at other HCA hospitals (new CFO at HCA Houston Healthcare Tomball; COO at an HCA Florida hospital). These operational leadership moves reduce execution risk around expansions and can improve operational performance over time. HCA names new CEO for TriStar StoneCrest Medical Center HCA Houston Healthcare Tomball names new CFO HCA Florida hospital names COO
• Positive Sentiment: Community giving — TriStar (an HCA affiliate) announced a $40,000 grant to the American Cancer Society Hope Lodge (Nashville), a modest PR win that supports local reputation and community relationships. TriStar announces $40,000 grant for ACS Hope Lodge in Nashville
• Neutral Sentiment: New emergency transport services — coverage of AirLife expanding timely emergency care is sector-positive for patient outcomes and throughput but has no direct, immediate financial read-through to HCA. AirLife takes flight, helping patients get timely emergency care
• Neutral Sentiment: Regulatory process color — reporting that VDH staff originally recommended denying the Chesterfield project highlights lingering regulatory scrutiny in certain markets; approval is positive but the back-and-forth indicates project risk exists. VDH staff first said no to new Chesterfield hospital. Why commissioner said yes.
• Negative Sentiment: Legislative/regulatory risk — Rep. Edwards is pushing a bill to give CMS authority to “take over” Mission Hospital, signaling heightened federal oversight and potential political/regulatory intervention for hospitals; investors may price increased compliance risk and operational uncertainty into shares. Rep. Edwards wants to give CMS ability to ‘take over’ Mission Hospital

Insider Activity at HCA Healthcare

In other news, EVP Michael R. Mcalevey sold 1,694 shares of the stock in a transaction dated Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the transaction, the executive vice president directly owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This represents a 16.06% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, SVP Jennifer Berres sold 8,020 shares of the company’s stock in a transaction that occurred on Wednesday, February 11th. The shares were sold at an average price of $514.58, for a total value of $4,126,931.60. Following the completion of the sale, the senior vice president owned 11,993 shares in the company, valued at approximately $6,171,357.94. This represents a 40.07% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 15,214 shares of company stock valued at $7,797,595 over the last three months. 1.50% of the stock is owned by corporate insiders.

HCA Healthcare Price Performance

HCA Healthcare stock opened at $472.68 on Wednesday. The business has a fifty day moving average price of $510.83 and a 200-day moving average price of $477.48. HCA Healthcare, Inc. has a 1-year low of $314.43 and a 1-year high of $556.52. The stock has a market capitalization of $105.68 billion, a price-to-earnings ratio of 16.66, a PEG ratio of 1.44 and a beta of 1.34.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, beating analysts’ consensus estimates of $7.37 by $0.64. HCA Healthcare had a negative return on equity of 409.11% and a net margin of 8.97%.The company had revenue of $19.51 billion during the quarter, compared to analysts’ expectations of $19.67 billion. During the same period last year, the business posted $6.22 earnings per share. The firm’s revenue was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 31st. Shareholders of record on Tuesday, March 17th were issued a $0.78 dividend. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Tuesday, March 17th. HCA Healthcare’s dividend payout ratio is 10.99%.

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.